Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

US Patent 12343393 · Granted Jul 1, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of u2025
PD-L1 analog fusion proteins for antigen specific immunotherapy and methods of u2025
Ultra-long acting insulin-Fc fusion protein and methods of use2025
Ultra-long acting insulin-Fc fusion protein and methods of use2025
Ultra-long acting insulin-Fc fusion protein2025
Ultra-long acting insulin-Fc fusion protein2025
BAFF-R antibodies and uses thereof2024
Ultra-long acting insulin-Fc fusion proteins and methods of use2024
Ultra-long acting insulin-Fc fusion proteins and methods of use2024
Ultra-long acting insulin-Fc fusion protein and methods of use2023
Ultra-long acting insulin-Fc fusion protein and methods of use2023
Ultra-long acting insulin-Fc fusion proteins and methods of use2023